No difference was found in the prognosis between genetic HRD cases with BRCA1/2 mutations and those with CHEK1 homozygous deletions or PTEN homozygous deletions. The gene discussed is BRCA1; the disease is hypoparathyroidism-retardation-dysmorphism syndrome.